A carregar...

Metabolomics analysis of hormone-responsive and triple-negative breast cancer cell responses to paclitaxel identify key metabolic differences

To date, no targeted therapies are available to treat triple negative breast cancer (TNBC), while other breast cancer subtypes are responsive to current therapeutic treatment. Metabolomics was conducted to reveal differences in two hormone receptor-negative TNBC cell lines and two hormone receptor-p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Proteome Res
Main Authors: Stewart, Delisha A., Winnike, Jason H., McRitchie, Susan L., Clark, Robert F., Pathmasiri, Wimal W., Sumner, Susan J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034715/
https://ncbi.nlm.nih.gov/pubmed/27447733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jproteome.6b00430
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!